Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome

<div>Landmark analysis of MACEs following stent implantation in whole and nondiabetic ACS patients. Kaplan-Meier survival curves (divided into two parts by the landmark point of 32 months) for MACEs (a) in the whole and (b) in non-DM population with ACS undergoing stent implantation by MCV level. Group 1, MCV-L; Group 2, MCV-M; Group 3, MCV-H.</div>

Disease Markers

fig3

Figure 3

Figure 3: Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome 

Figure 3 | Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome 